Topics

Update: Liver Gene Therapy 8 Times Stronger Than Usual

05:10 EST 6 Dec 2018 | Labiotech.eu

Update (06/12/2018): uniQure has incorporated Synpromics’ strong liver promoter into a preclinical gene therapy candidate for treating hemophilia A. Published on 08/10/2018 Synpromics and uniQure have unveiled new technology for precise genetic control that could make gene therapy safer and ...

The post Update: Liver Gene Therapy 8 Times Stronger Than Usual appeared first on Labiotech.eu.

Original Article: Update: Liver Gene Therapy 8 Times Stronger Than Usual

NEXT ARTICLE

More From BioPortfolio on "Update: Liver Gene Therapy 8 Times Stronger Than Usual"

Quick Search

Relevant Topics

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...